The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.
Clinical diagnostic criteria for dementia associated with Parkinson’s disease
Open accessAbstract
Dementia has been increasingly more recognized to be a common feature in patients with Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of dementia associated with PD (PD‐D), however, have been lacking. A Task Force, organized by the Movement Disorder Study, was charged with the development of clinical diagnostic criteria for PD‐D. The Task Force members were assigned to sub‐committees and performed a systematic review of the literature, based on pre‐defined selection criteria, in order to identify the epidemiological, clinical, auxillary, and pathological features of PD‐D. Clinical diagnostic criteria were then developed based on these findings and group consensus. The incidence of dementia in PD is increased up to six times, point‐prevelance is close to 30%, older age and akinetic‐rigid form are associated with higher risk. PD‐D is characterized by impairment in attention, memory, executive and visuo‐spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent. There are no specific ancillary investigations for the diagnosis; the main pathological correlate is Lewy body‐type degeneration in cerebral cortex and limbic structures. Based on the characteristic features associated with this condition, clinical diagnostic criteria for probable and possible PD‐D are proposed. © 2007 Movement Disorder Society
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Final diagnoses were based on internationally established criteria [12, 46, 49–52].”
Citations
Cites
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Self-citationDiagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citationα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., ZACCAI, J. H., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,714
Self-citationPrevalence and Characteristics of Dementia in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403
Self-citationRivastigmine for Dementia Associated with Parkinson's Disease
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., Deyn, P. P. D., Durif, F., Kulisevsky, J., van Laar, T., Lees, A. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,219
Self-citationSydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fénelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,035
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,006
Goldman, J. G., Stebbins, G. T., Dinh, V., Bernard, B. A., Merkitch, D., deToledo‐Morrell, L., & Goetz, C. G. (2014) · Brain · doi:10.1093/brain/awt360 · Cited by 155
Self-citationVallerga, C. L., Zhang, F., Fowdar, J., McRae, A. F., Qi, T., Nabais, M. F., Zhang, Q., Kassam, I., Henders, A. K., Wallace, L. M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15065-7 · Cited by 153
Christopher, L., Marras, C., Duff-Canning, S. J., Koshimori, Y., Chen, R. E., Boileau, I., Segura, B., Monchi, O., Lang, A. E., Rusjan, P., et al. (2013) · Brain · doi:10.1093/brain/awt337 · Cited by 151
Cut‐off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease
Llebaria, G., Pagonabarraga, J., Kulisevsky, J., García‐Sánchez, C., Pascual‐Sedano, B., Gironell, A., & Martínez‐Corral, M. (2008) · Movement Disorders · doi:10.1002/mds.22173 · Cited by 150
Dysfunctional brain dynamics and their origin in Lewy body dementia
Schumacher, J., Peraza, L. R., Firbank, M., Thomas, A. J., Kaiser, M., Gallagher, P., O'Brien, J. T., Blamire, A. M., & Taylor, J. (2019) · Brain · doi:10.1093/brain/awz069 · Cited by 149
The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status
Song, S., Lee, J. E., Park, H., Sohn, Y. H., Lee, J. D., & Lee, P. H. (2011) · Movement Disorders · doi:10.1002/mds.23477 · Cited by 147
Lawson, R. A., Yarnall, A. J., Duncan, G. W., Khoo, T. K., Breen, D. P., Barker, R. A., Collerton, D., Taylor, J., & Burn, D. J. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.07.004 · Cited by 148
Self-citationThe N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease
Russell, A. C., Šimurina, M., Garcia, M., Novokmet, M., Wang, Y., Rudan, I., Campbell, H. J., Lauc, G., Thomas, M. G., & Wang, W. (2017) · Glycobiology · doi:10.1093/glycob/cwx022 · Cited by 150
Rongve, A., Boeve, B. F., & Aarsland, D. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02733.x · Cited by 154
Self-citationAmyloid imaging of Lewy body‐associated disorders
Foster, E. R., Campbell, M. C., Burack, M. A., Hartlein, J. M., Flores, H. P., Cairns, N. J., Hershey, T. G., & Perlmutter, J. S. (2010) · Movement Disorders · doi:10.1002/mds.23393 · Cited by 147
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study
Santangelo, G., Vitale, C., Picillo, M., Moccia, M., Cuoco, S., Longo, K., Pezzella, D., di Grazia, A., Erro, R., Pellecchia, M. T., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.08.024 · Cited by 149
Carrière, N., Besson, P., Dujardin, K., Duhamel, A., Defebvre, L., Delmaire, C., & Devos, D. (2014) · Movement Disorders · doi:10.1002/mds.25904 · Cited by 147
Hou, X., Fiesel, F. C., Truban, D., Castanedes Casey, M., Lin, W.-L., Soto, A. I., Tacik, P., Rousseau, L. G., Diehl, N. N., Heckman, M. G., et al. (2018) · Autophagy · doi:10.1080/15548627.2018.1461294 · Cited by 147
Self-citationAssociation of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease
Kim, J., Oh, Y., Lee, K.-S., Kim, Y.-I., Yang, D., & Goldstein, D. S. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1acd · Cited by 146
Cognitive function in the early phase of Parkinson's disease, a five-year follow-up
Domellöf, M., Ekman, U., Forsgren, L., & Elgh, E. (2015) · Acta Neurologica Scandinavica · doi:10.1111/ane.12375 · Cited by 160
Suemoto, C. K., Ferretti‐Rebustini, R. E. D. L., Rodriguez, R. D., Leite, R. E. P., Soterio, L., Brucki, S. M. D., Spera, R. R., Cippiciani, T. M., Farfel, J. M., Filho, A. D. P. C., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002267 · Cited by 152
Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders
Coughlin, D. G., Xie, S. X., Liang, M., Williams, A., Peterson, C. S., Weintraub, D. A., McMillan, C. T., Wolk, D. A., Akhtar, R. S., Hurtig, H. I., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25392 · Cited by 150
Cognitive impairment in Parkinson's disease and dementia with Lewy bodies
Aarsland, D. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.034 · Cited by 145
Self-citationThe nucleus basalis of Meynert: A new target for deep brain stimulation in dementia?
Gratwicke, J., Kahan, J., Zrinzo, L. U., Hariz, M. I., Limousin, P. D., Foltynie, T., & Jahanshahi, M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.09.003 · Cited by 148
Short-term memory binding is impaired in AD but not in non-AD dementias
Sala, S. D., Parra, M. A., Fabi, K., Luzzi, S., & Abrahams, S. (2012) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2012.01.018 · Cited by 142
Lee, J. E., Cho, K. H., Song, S. K., Kim, H. J., Lee, H. S., Sohn, Y. H., & Lee, P. H. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305062 · Cited by 154
New landscape of the diagnosis of Alzheimer’s disease
Frisoni, G. B., Hansson, O., Nichols, E., Garibotto, V., Schindler, S. E., van der Flier, W. M., Jessen, F., Villain, N., Arenaza-Urquijo, E. M., Crivelli, L., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01294-2 · Cited by 143
Self-citationCerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia.
Compta, Y., Santamaria, J., Ratti, L., Tolosa, E., Iranzo, Á., Muñoz, E., Valldeoriola, F., Casamitjana, R., Ríos, J., & Marti, M. (2009) · Brain : a journal of neurology · doi:10.1093/brain/awp263 · Cited by 146
Self-citationConversion to MCI and dementia in Parkinson's disease: a systematic review and meta-analysis
Saredakis, D., Collins‐Praino, L. E., Gutteridge, D. S., Stephan, B. C. M., & Keage, H. A. D. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.04.020 · Cited by 153
Trial of pimavanserin in dementia-related psychosis
Tariot, P. N., Cummings, J. L., Soto-Martin, M. E., Ballard, C., Erten-Lyons, D., Sultzer, D. L., Devanand, D. P., Weintraub, D., McEvoy, B., Youakim, J. M., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034634 · Cited by 145
Self-citationWennström, M., Surova, Y., Hall, S., Nilsson, C., Minthon, L., Boström, F., Hansson, O., & Nielsen, H. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053250 · Cited by 141
Increased CSF biomarkers of angiogenesis in Parkinson disease
Janelidze, S., Lindqvist, D., Francardo, V., Hall, S., Zetterberg, H., Blennow, K., Adler, C. H., Beach, T. G., Serrano, G. E., van Westen, D., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002151 · Cited by 150
The spectrum of cognitive impairment in Lewy body diseases
Goldman, J. G., Williams‐Gray, C. H., Barker, R. A., Duda, J. E., & Galvin, J. E. (2014) · Movement Disorders · doi:10.1002/mds.25866 · Cited by 146
Self-citationZhu, K., van Hilten, J. J., & Marinus, J. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.06.006 · Cited by 147
Bilateral Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia
Gratwicke, J., Zrinzo, L. U., Kahan, J., Peters, A., Beigi, M., Akram, H., Hyam, J. A., Oswal, A., Day, B. L., Mancini, L., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3762 · Cited by 141
Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease
Bolitho, S. J., Naismith, S. L., Rajaratnam, S. M. W., Grunstein, R. R., Hodges, J. R., Terpening, Z., Rogers, N., & Lewis, S. J. G. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2013.10.016 · Cited by 139
Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson’s Disease
Pagonabarraga, J., Corcuera‐Solano, I., Vives‐Gilabert, Y., Llebaria, G., García‐Sánchez, C., Pascual‐Sedano, B., Delfino, M., Kulisevsky, J., & Gómez‐Ansón, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054980 · Cited by 149
Resting bold fMRI differentiates dementia with Lewy bodies vs Alzheimer disease
Galvin, J. E., Price, J. L., Yan, Z., Morris, J. C., & Sheline, Y. I. (2011) · Neurology · doi:10.1212/wnl.0b013e31821ccc83 · Cited by 137
Randomized controlled trial of memantine in dementia associated with Parkinson's disease
Leroi, I., Overshott, R., Byrne, E. J., Daniel, E., & Burns, A. S. (2009) · Movement Disorders · doi:10.1002/mds.22495 · Cited by 140
Characterizing mild cognitive impairment in Parkinson's disease
Dalrymple‐Alford, J. C., Livingston, L., MacAskill, M. R., Graham, C., Melzer, T. R., Porter, R., Watts, R., & Anderson, T. (2011) · Movement Disorders · doi:10.1002/mds.23592 · Cited by 146
Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease
Cholerton, B., Johnson, C. O., Fish, B. E., Quinn, J. F., Chung, K. A., Peterson‐Hiller, A. L., Rosenthal, L. S., Dawson, T. M., Albert, M., Hu, S., et al. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.02.007 · Cited by 137
Challenges of multimorbidity of the aging brain: a critical update
Jellinger, K. A., & Attems, J. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-014-1288-x · Cited by 154
Expanding the clinical phenotype of SNCA duplication carriers
Nishioka, K., Ross, O. A., Ishii, K., Kachergus, J. M., Ishiwata, K., Kitagawa, M., Kono, S., Obi, T., Mizoguchi, K., Inoue, Y., et al. (2009) · Movement Disorders · doi:10.1002/mds.22682 · Cited by 135
Self-citationBirba, A., García-Cordero, I., Kozono, G., Legaz, A., Ibáñez, A., Sedeño, L., & García, A. M. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.07.011 · Cited by 128
A semi‐structured interview to assess visual hallucinations in older people
Mosimann, U. P., Collerton, D., Dudley, R. E. J., Meyer, T. D., Graham, G., Dean, J. L., Bearn, D., Killen, A., Dickinson, L., Clarke, M. P., et al. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1965 · Cited by 135
Self-citationOeckl, P., Metzger, F., Nagl, M., Arnim, C. A. F. V., Halbgebauer, S., Steinacker, P., Ludolph, A. C., & Otto, M. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m116.059915 · Cited by 140
Chiasserini, D., Biscetti, L., Eusebi, P., Salvadori, N., Frattini, G., Simoni, S., Roeck, N. D., Tambasco, N., Stoops, E., Vanderstichele, H., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0276-4 · Cited by 139
Shine, J. M., Halliday, G. M., Gilat, M., Matar, E., Bolitho, S., Carlos, M., Naismith, S. L., & Lewis, S. J. G. (2013) · Human Brain Mapping · doi:10.1002/hbm.22321 · Cited by 133
Gorges, M., Müller, H., Lulé, D. E., Pinkhardt, E. H., Ludolph, A. C., & Kassubek, J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.026 · Cited by 134
Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathy
Baggio, H. C., Segura, B., Garrido‐Millan, J. L., Marti, M., Compta, Y., Valldeoriola, F., Tolosa, E., & Junque, C. (2015) · Movement Disorders · doi:10.1002/mds.26137 · Cited by 131
Cognitive impairment in nondemented Parkinson's disease
Barone, P., Aarsland, D., Burn, D. J., Emre, M., Kulisevsky, J., & Weintraub, D. A. (2011) · Movement Disorders · doi:10.1002/mds.23919 · Cited by 131
Self-citationÖzdilek, B., & Kenangıl, G. (2014) · The Clinical Neuropsychologist · doi:10.1080/13854046.2014.881554 · Cited by 134
Validation of the non-motor symptoms questionnaire (NMS-Quest)
Romenets, S. R., Wolfson, C. M., Galatas, C., Pelletier, A., Altman, R., Wadup, L., & Postuma, R. B. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.08.013 · Cited by 131
Hosokai, Y., Nishio, Y., Hirayama, K., Takeda, A., Ishioka, T., Sawada, Y., Suzuki, K., Itoyama, Y., Takahashi, S., Fukuda, H., et al. (2009) · Movement Disorders · doi:10.1002/mds.22444 · Cited by 132
Predictors of caregiver burden in aged caregivers of demented older patients
Tsai, C.-F., Hwang, W.-S., Lee, J., Wang, W.-F., Huang, L., Huang, L.-K., Lee, W., Sung, P., Liu, Y., Hsu, C.-C., et al. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02007-1 · Cited by 145
Structural correlates of facial emotion recognition deficits in Parkinson's disease patients
Baggio, H. C., Segura, B., Ibarretxe-Bilbao, N., Valldeoriola, F., Marti, M. J., Compta, Y., Tolosa, E., & Junqué, C. (2012) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2012.05.020 · Cited by 128
Self-citationCognitive training interventions for dementia and mild cognitive impairment in Parkinson’s disease
Orgeta, V., McDonald, K. R., Poliakoff, E., Hindle, J. V., Clare, L., & Leroi, I. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011961.pub2 · Cited by 144
Tsuboi, Y., Uchikado, H., & Dickson, D. W. (2007) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(08)70005-1 · Cited by 125
Self-citationPsychiatric Manifestation in Patients with Parkinson's Disease
Han, J. W., Ahn, Y. D., Kim, W.-S., Shin, C. M., Jeong, S. J., Song, Y. S., Bae, Y. J., & Kim, J.-M. (2018) · Journal of Korean Medical Science · doi:10.3346/jkms.2018.33.e300 · Cited by 127
Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases
Coughlin, D. G., Hurtig, H. I., & Irwin, D. J. (2019) · Movement Disorders · doi:10.1002/mds.27867 · Cited by 132
Evidence in favor of Braak staging of Parkinson's disease
Dickson, D. W., Uchikado, H., Fujishiro, H., & Tsuboi, Y. (2010) · Movement Disorders · doi:10.1002/mds.22637 · Cited by 126
Self-citationDeep Brain Stimulation for the Treatment of Alzheimer Disease and Dementias
Laxton, A. W., & Lozano, A. M. (2012) · World Neurosurgery · doi:10.1016/j.wneu.2012.06.028 · Cited by 126
Future thinking in Parkinson's disease: An executive function?
Vito, S. D., Gamboz, N., Brandimonte, M. A., Barone, P., Amboni, M., & Sala, S. D. (2012) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2012.03.001 · Cited by 125
Screening for Mild Cognitive Impairment: Comparison of “MCI Specific” Screening Instruments
Ó’Caoimh, R., Timmons, S., & Molloy, D. W. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150881 · Cited by 130
van Steenoven, I., Aarsland, D., Hurtig, H. H., Chen‐Plotkin, A. S., Duda, J. E., Rick, J. H., Chahine, L. M., Dahodwala, N. A., Trojanowski, J. Q., Roalf, D. R., et al. (2014) · Movement Disorders · doi:10.1002/mds.26062 · Cited by 121
Self-citationvan Steenoven, I., Aarsland, D., Weintraub, D. A., Londos, E., Blanc, F., van der Flier, W. M., Teunissen, C. E., Mollenhauer, B., Fladby, T., Kramberger, M. G., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160322 · Cited by 123
Self-citationPerformance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease
Hall, S., Orru, C. D., Serrano, G. E., Galasko, D. R., Hughson, A. G., Groveman, B. R., Adler, C. H., Beach, T. G., Caughey, B. W., & Hansson, O. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01388-7 · Cited by 128
Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease
Lee, J., Kim, J. M., Ahn, J., Kim, H., Jeon, B. S., & Kim, T. W. (2013) · Movement Disorders · doi:10.1002/mds.25543 · Cited by 122
Rivastigmine for mild cognitive impairment in Parkinson disease: A placebo‐controlled study
Mamikonyan, E., Xie, S. X., Melvin, E., & Weintraub, D. A. (2015) · Movement Disorders · doi:10.1002/mds.26236 · Cited by 122
Treatment of Psychosis and Dementia in Parkinson’s Disease
Goldman, J. G., & Holden, S. K. (2014) · Current Treatment Options in Neurology · doi:10.1007/s11940-013-0281-2 · Cited by 121
Self-citationOccurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study
Pedersen, K. F., Alves, G. W., Aarsland, D., & Larsen, J. P. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.170043 · Cited by 121
Self-citationPetrovic, I. N., Ling, H., Asi, Y. T., Ahmed, Z., Kukkle, P. L., Hazrati, L., Lang, A. E., Révész, T., Holton, J. L., & Lees, A. J. (2012) · Movement Disorders · doi:10.1002/mds.25115 · Cited by 121
Self-citationRegional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait
Tessitore, A., Amboni, M., Cirillo, G., Corbo, D., Picillo, M., Russo, A., Vitale, C., Santangelo, G., Erro, R., Cirillo, M., et al. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3066 · Cited by 129
Clinical Features in Early Parkinson Disease and Survival
Lo, R. Y., Tanner, C. M., Albers, K. B., Leimpeter, A. D., Fross, R. D., BERNSTEIN, A. L., McGuire, V. M., Quesenberry, C. P., Nelson, L. M., & Eeden, S. K. V. D. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.221 · Cited by 122
Wang, Y., Hancock, A. M., Bradner, J. M., Chung, K. A., Quinn, J. F., Peskind, E. R., Galasko, D. R., Jankovic, J. J., Zabetian, C. P., Kim, H. M., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.01.006 · Cited by 121
Cognition, language, and clinical pathological features of non-Alzheimer's dementias: An overview
Reilly, J. J., Rodriguez, A. D., Lamy, M., & Neils‐Strunjas, J. (2010) · Journal of Communication Disorders · doi:10.1016/j.jcomdis.2010.04.011 · Cited by 129
Mild cognitive impairment in Parkinson’s disease: the Parkinson’s disease cognitive study (PACOS)
Monastero, R., Cicero, C. E., Baschi, R., Davì, M., Luca, A., Restivo, V., Zangara, C., Fierro, B., Zappia, M., & Nicoletti, A. S. Q. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8800-4 · Cited by 122
GBA and APOE Impact Cognitive Decline in Parkinson's Disease: A 10‐Year Population‐Based Study
Szwedo, A. A., Dalen, I., Pedersen, K. F., Camacho, M., Bäckström, D. C., Forsgren, L., Tzoulis, C., Winder‐Rhodes, S., Hudson, G., Liu, G., et al. (2022) · Movement Disorders · doi:10.1002/mds.28932 · Cited by 120
Janzen, J., Ent, D. V. ‘., Lemstra, A. W., Berendse, H. W., Barkhof, F., & Foncke, E. M. J. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6149-z · Cited by 120
Amyloid PET Imaging in Lewy Body Disorders
Donaghy, P. C., Thomas, A. J., & O'Brien, J. T. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.03.001 · Cited by 118
Ruppert, M. C., Greuel, A., Tahmasian, M., Schwartz, F., Stürmer, S., Maier, F., Hammes, J., Tittgemeyer, M., Timmermann, L., van Eimeren, T., et al. (2020) · Brain · doi:10.1093/brain/awaa019 · Cited by 119
García‐García, D., Clavero, P., Gasca‐Salas, C., Lamet, I., Arbizu, J., Gonzalez-Redondo, R., Obeso, J. A., & Rodríguez-Oroz, M. C. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2198-5 · Cited by 125
Supine hypertension in Parkinson’s disease and multiple system atrophy
Fanciulli, A., Göbel, G., Ndayisaba, J. P., Granata, R., Duerr, S., Strano, S., Colosimo, C., Poewe, W. H., Pontieri, F. E., & Wenning, G. K. (2016) · Clinical Autonomic Research · doi:10.1007/s10286-015-0336-4 · Cited by 118
Self-citationSeeding variability of different alpha synuclein strains in synucleinopathies
Candelise, N., Schmitz, M., Llorens, F., Villar‐Piqué, A., Cramm, M., Thom, T., Correia, S., da Cunha, J. E. G., Möbius, W., Outeiro, T. F., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25446 · Cited by 122
Goldman, J. G., Holden, S. K., Bernard, B. A., Ouyang, B., Goetz, C. G., & Stebbins, G. T. (2013) · Movement Disorders · doi:10.1002/mds.25655 · Cited by 127
Self-citationGalvin, J. E., Duda, J. E., Kaufer, D., Lippa, C. F., Taylor, A., & Zarit, S. H. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181c72b5d · Cited by 119
Examining carer stress in dementia: the role of subtype diagnosis and neuropsychiatric symptoms
Lee, D. R., McKeith, I. G., Mosimann, U. P., Ghosh‐Nodyal, A., & Thomas, A. J. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3799 · Cited by 115
Self-citationCognitive Impairment and Dementia in Parkinson Disease
Goldman, J. G., & Sieg, E. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.01.001 · Cited by 116
Self-citationBellomo, G., Toja, A., Paoletti, F. P., Ma, Y., Farris, C. M., Gaetani, L., Salvadori, N., Chiasserini, D., Wojdała, A. L., Concha‐Marambio, L., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13658 · Cited by 117
Lee, J., Park, H., Park, B., Song, S. K., Sohn, Y. H., Lee, J. D., & Lee, P. H. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.184747 · Cited by 114
Differentiating dementia disease subtypes with gait analysis: feasibility of wearable sensors?
Ardle, R. M., Din, S. D., Galna, B., Thomas, A. J., & Rochester, L. (2019) · Gait & Posture · doi:10.1016/j.gaitpost.2019.12.028 · Cited by 114
Llorens, F., Hermann, P., Villar‐Piqué, A., Lucena, D. D., Nägga, K., Hansson, O., Santana, I. J., Schmitz, M., Schmidt, C., Varges, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14373-2 · Cited by 115
Episodic recognition memory and the hippocampus in Parkinson's disease: A review
Das, T., Hwang, J. J., & Poston, K. L. (2018) · Cortex · doi:10.1016/j.cortex.2018.11.021 · Cited by 121
Clinical significance of REM sleep behavior disorder in Parkinson’s disease
Nomura, T., Inoue, Y., Kagimura, T., & Nakashima, K. (2012) · Sleep Medicine · doi:10.1016/j.sleep.2012.10.011 · Cited by 111
Babiloni, C., Percio, C. D., Lizio, R., Noce, G., Cordone, S., Lopez, S., Soricelli, A., Ferri, R., Pascarelli, M. T., Nobili, F. M., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.03.030 · Cited by 117
Self-citationDugger, B. N., Boeve, B. F., Murray, M. E., Parisi, J. E., Fujishiro, H., Dickson, D. W., & Ferman, T. J. (2011) · Movement Disorders · doi:10.1002/mds.24003 · Cited by 110
Self-citationCognitive training in Parkinson disease
Zimmermann, R., Gschwandtner, U., Benz, N., Hatz, F., Schindler, C., Taub, E., & Fuhr, P. (2014) · Neurology · doi:10.1212/wnl.0000000000000287 · Cited by 109
Sanford, A. M. (2018) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2018.06.007 · Cited by 122
Diagnosis and management of Parkinson’s disease dementia
Poewe, W. H., Gauthier, S. G., Aarsland, D., Leverenz, J. B., Barone, P., Weintraub, D. A., TOLOSA, E. S., & Dubois, B. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2008.01869.x · Cited by 109
Self-citationGBA Variants Influence Motor and Non-Motor Features of Parkinson’s Disease
Jesús, S., Huertas, I., Bernal‐Bernal, I., Bonilla‐Toribio, M., Cáceres‐Redondo, M. T., Vargas‐González, L., Gómez-Llamas, M., Carrillo, F., Calderón, E. J., Carballo, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167749 · Cited by 108
Salience network and parahippocampal dopamine dysfunction in memory‐impaired Parkinson disease
Christopher, L., Duff-Canning, S. J., Koshimori, Y., Segura, B., Boileau, I., Chen, R. E., Lang, A. E., Houle, S., Rusjan, P., & Strafella, A. P. (2014) · Annals of Neurology · doi:10.1002/ana.24323 · Cited by 108
Clinical differences among mild cognitive impairment subtypes in Parkinson's disease
Goldman, J. G., Weis, H., Stebbins, G. T., Bernard, B. A., & Goetz, C. G. (2012) · Movement Disorders · doi:10.1002/mds.25062 · Cited by 110
Self-citationMcKeith, I. G., Taylor, J., Thomas, A. J., Donaghy, P. C., & Kane, J. P. M. (2016) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988716656083 · Cited by 108
Self-citationFunctional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease
Hassan, M., Chaton, L., Benquet, P., Delval, A., Leroy, C., Plomhause, L., Moonen, A. J. H., Duits, A., Leentjens, A. F. G., van Kranen-Mastenbroek, V. H. J. M., et al. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.03.002 · Cited by 107
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease
Irwin, D. J., Fedler, J. K., Coffey, C. S., Caspell‐Garcia, C., Kang, J., Simuni, T., Foroud, T., Toga, A. W., Tanner, C. M., Kieburtz, K. D., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25811 · Cited by 108
Metadata
- Authors
- Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., Goldman, J., Goetz, C., Korczyn, A., Lees, A., Levy, R., Litvan, I., McKeith, I., Olanow, W., Poewe, W., Quinn, N., Sampaio, C., Tolosa, E., & Dubois, B.
- Affiliations
- Istanbul University (TR)
- Stavanger University Hospital (NO)
- King's College London (GB)
- Newcastle University (GB)
- Inserm (FR)
- Juntendo University (JP)
- UNSW Sydney (AU)
- University of California, Los Angeles (US)
- Mayo Clinic (US)
- McGill University Research Centre for Studies in Aging (CA)
- Rush University Medical Center (US)
- Tel Aviv University (IL)
- National Hospital for Neurology and Neurosurgery (GB)
- University of Louisville (US)
- Newcastle upon Tyne Hospital (GB)
- Icahn School of Medicine at Mount Sinai (US)
- Innsbruck Medical University (AT)
- University of Lisbon (PT)
- Hospital Clínic de Barcelona (ES)
- Corresponding author
- Emre, Murat
- ORCID
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2007-05-31
- Volume
- 22
- Issue
- 12
- Pages
- 1689-1707
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2166609052
- Cited by
- 3,027
- References
- 187
- Citations by year
- 2026: 141 · 2025: 203 · 2024: 192 · 2023: 174 · 2022: 253 · 2021: 215 · 2020: 202 · 2019: 189 · 2018: 173 · 2017: 153 · 2016: 177 · 2015: 151 · 2014: 161 · 2013: 157 · 2012: 137
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Movement Disorders (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Medical Research Council (G0400074)
- National Institute on Aging (R01AG024040)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Keywords
- Parkinson's disease dementia, clinical criteria, Lewy bodies, dementia prevalence, executive dysfunction, memory impairment, hallucinations, apathy, behavioral symptoms
- MeSH terms
- Dementia, Diagnosis, Differential, Humans, Neuropsychological Tests, Parkinson Disease, Severity of Illness Index, Task Performance and Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
